Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Sensitive radioimmunoassays for 0/sup 6/-n-butyldeoxyguanosine, 0/sup 2/-n-butylthymidine and 0/sup 4/-n-butylthymidine

Journal Article · · Carcinogenesis (N.Y.); (United States)
; ;  [1]
  1. Christie Hospital and Holt Radium Inst., Manchester (UK). Paterson Labs.
Radioimmunoassays have been developed using monoclonal antibodies from hybridomas raised against bovine serum albumin conjugates of 0/sup 6/-n-butyldeoxyguanosine, 0/sup 2/-n-butylthymidine riboside and 0/sup 4/-n-butylthymidine riboside. The assays showed 50% inhibition of binding of specific (/sup 3/H)butyl-deoxynucleosides by 0.044, 0.069 and 0.45 pmole of cold 0/sup 6/-n-butyldeoxyguanosine, 0/sup 2/-n-butylthymidine and 0/sup 4/-n-butylthymidine respectively, corresponding to affinity constants of 2.7 x 10/sup 10/, 1.1 x 10/sup 10/ and 8.8 x 10/sup 8/ respectively. In competitive radioimmunoassays a similar degree of inhibition required approximately 10/sup 7/-fold higher concentrations of normal deoxynucleotides. From the relative inhibitions produced by a wide range of alkylated and normal nucleosides and bases it was concluded that each antibody primarily recognises butylation, as compared to other alkylations, at the sites specified by the immunogen. The radioimmunoassays should be suitable for the detection of these potentially promutagenic lesions in digests of DNA exposed to low (biological) levels of butylation.
OSTI ID:
6717889
Journal Information:
Carcinogenesis (N.Y.); (United States), Journal Name: Carcinogenesis (N.Y.); (United States) Vol. 3:5; ISSN CRNGD
Country of Publication:
United States
Language:
English